Clinical study on effect of Hijama-bila-shurt (Dry cupping) in the management of fibromyalgia syndrome
Author(s):
Sumayya Parvez, Mohd Anwar, Hammad Usmani, Mohammad Saad A Khan and S Javed Ali
Abstract:
This study intended to evaluate the effect of Hijama-Bila-Shurt (Dry cupping) alone and Hijama-Bila-Shurt with Habbe Asgand as a part of multimodal approach in the management of Fibromyalgia (FM) by using NRS scale and a functional improvement in FM related symptoms in Fibromyalgia Syndrome(FMS) by using FIQR. The study was designed as open, randomized and controlled clinical trial carried out on total 60 patients in which they were divided into 3 groups, Test Group ‘A’ & ‘B’ and Control Group ‘C’ containing 20 patients in each group. Group A received only Hijama-Bila-Shurt (Dry Cupping), Group B received Hijama-Bila-Shurt & Habbe Asgand and Group C received Amitriptyline as standard drug. The improvement in Group A, at the end of study was statistically not significant at p>0.05. In Group B and C it was found statistically significant p<0.05 for both NRS and FIQR which cinclude that Hijama-Bila-Shurt along with Habbe-Asgandh is found as effective as the control drug Amitriptyline in the management of Fibromyalgia related syndrome.
How to cite this article:
Sumayya Parvez, Mohd Anwar, Hammad Usmani, Mohammad Saad A Khan and S Javed Ali. Clinical study on effect of Hijama-bila-shurt (Dry cupping) in the management of fibromyalgia syndrome. The Pharma Innovation Journal. 2023; 12(10S): 1020-1025.